These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23819105)

  • 1. Phage therapy: Should bacterial resistance to phages be a concern, even in the long run?
    Ormälä AM; Jalasvuori M
    Bacteriophage; 2013 Jan; 3(1):e24219. PubMed ID: 23819105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage steering of antibiotic-resistance evolution in the bacterial pathogen,
    Gurney J; Pradier L; Griffin JS; Gougat-Barbera C; Chan BK; Turner PE; Kaltz O; Hochberg ME
    Evol Med Public Health; 2020; 2020(1):148-157. PubMed ID: 34254028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli.
    Valério N; Oliveira C; Jesus V; Branco T; Pereira C; Moreirinha C; Almeida A
    Virus Res; 2017 Aug; 240():8-17. PubMed ID: 28746884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadscale phage therapy is unlikely to select for widespread evolution of bacterial resistance to virus infection.
    Cohan FM; Zandi M; Turner PE
    Virus Evol; 2020 Jul; 6(2):veaa060. PubMed ID: 33365149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.
    Lin DM; Koskella B; Lin HC
    World J Gastrointest Pharmacol Ther; 2017 Aug; 8(3):162-173. PubMed ID: 28828194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary and co-evolutionary phage training approaches enhance bacterial suppression and delay the emergence of phage resistance.
    Ngiam L; Weynberg K; Guo J
    ISME Commun; 2024 Jan; 4(1):ycae082. PubMed ID: 38988700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The untapped potential of phage model systems as therapeutic agents.
    Romeyer Dherbey J; Bertels F
    Virus Evol; 2024; 10(1):veae007. PubMed ID: 38361821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination therapy of Phages and Antibiotics: Two is better than one.
    Li X; He Y; Wang Z; Wei J; Hu T; Si J; Tao G; Zhang L; Xie L; Abdalla AE; Wang G; Li Y; Teng T
    Int J Biol Sci; 2021; 17(13):3573-3582. PubMed ID: 34512166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.
    Zhang QG; Buckling A
    Evol Appl; 2012 Sep; 5(6):575-82. PubMed ID: 23028398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulation and Delivery of Therapeutic Phages.
    Loh B; Gondil VS; Manohar P; Khan FM; Yang H; Leptihn S
    Appl Environ Microbiol; 2021 Mar; 87(5):. PubMed ID: 33310718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel "Superspreader" Bacteriophages Promote Horizontal Gene Transfer by Transformation.
    Keen EC; Bliskovsky VV; Malagon F; Baker JD; Prince JS; Klaus JS; Adhya SL
    mBio; 2017 Jan; 8(1):. PubMed ID: 28096488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophage and Bacterial Susceptibility, Resistance, and Tolerance to Antibiotics.
    Chen Q; Dharmaraj T; Cai PC; Burgener EB; Haddock NL; Spakowitz AJ; Bollyky PL
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibilities of bacteriophage therapy].
    Skurnik M; Kiljunen S
    Duodecim; 2016; 132(8):712-9. PubMed ID: 27244930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Co-occurrence Networks Reflect Bacteriophage Ecology and Evolution.
    Shapiro JW; Putonti C
    mBio; 2018 Mar; 9(2):. PubMed ID: 29559574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.